Oncology

Oncology
Product Description

Biophore Pharma INC.

  • Country/Region:
    United States
  • On CPHI since:
    2015
  • Certificates:
    3
Company types
Contract Service
Manufacturer/Innovator

Biophore Pharma INC.

  • Country/Region:
    United States
  • On CPHI since:
    2015
  • Certificates:
    3
Company types
Contract Service
Manufacturer/Innovator

More Products from Biophore Pharma INC. (62)

  • Trifluridine

    Product Trifluridine

    Trifluridine is an Antiviral agent indicated for the treatment of of primary kerato conjunctivitis and recurrent epithelial keratitis.
  • DOTA

    Product DOTA

    DOTA is an Chelating agent

    Biophore's DOTA:   All impurities below 0.07 (% w/w), Stringent control on sodium and chloride, Stable at room temperature, Commercialized product for Europe.
  • DTPA

    Product DTPA

    DTPA is an Chelating agent

    Biophore's DTPA: Stringent control on Iron content,  All impurities below 0.01
  • Trientine

    Product Trientine

    Trientinen is indicated for the treatment of  patients with Wilson's disease who are intolerant of penicillamine.

    Biophore's Trientine: DMF Filed

  • Cannabidiol API (CBD)

    Product Cannabidiol API (CBD)

    Ultrapure synthetic cannabidiol with US DMF
  • Aviptadil
  • Benserazide
  • Carfilzomib
  • Cladribine
  • Cyclen
  • Development and manufacture of pharmaceutical actives

    Product Development and manufacture of pharmaceutical actives

    Biophore pharma inc offers services which includes development and manufacture of pharmaceutical actives. Features: it is used for oncology medications, contrast and diagnostic media. Contact us for more information.

Biophore Pharma INC. resources (2)